[1]
A. Ovčinikova and R. Kizlaitienė, “Multiple sclerosis: overview of orally administrated disease-modifying drugs. Do genetics influence the success of treatment?”, NS, vol. 23, no. 1(79), pp. 20–25, Mar. 2019, doi: 10.29014/ns.2019.03.